Evidence map›Paper›PMID 33566273›Full record

ArticleEcotoxicology (London, England)2021

Comparative selectivity of nano and commercial formulations of pirimicarb on a target pest, Brevicoryne brassicae, and its predator Chrysoperla carnea.

Nariman Maroofpour, Mahdieh Mousavi, Mir Jalil Hejazi, Shahzad Iranipour, Hamed Hamishehkar, Nicolas Desneux, Antonio Biondi, Khalid Haddi

Abstract read
PubMed Publisher
In one paragraph

Article in Ecotoxicology (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Synthetic Strategies for the Development of Novel Heterocycles as Larvicides TargetingMedicinal chemistry (Shariqah (United Arab Emirates)) · 2025
    Review
  4. Article
  5. Article
  6. International journal of molecular sciences · 2023
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nariman MaroofpourDepartment of Plant Protection, Faculty of Agriculture, University of Tabriz, Tabriz, Iran. n.maroofpoor@tabrizu.ac.ir.ORCID http://orcid.org/0000-0002-8301-2079
Mahdieh MousaviDepartment of Plant Protection, Faculty of Agriculture, Urmia University, Urmia, Iran.
Mir Jalil HejaziDepartment of Plant Protection, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.
Shahzad IranipourDepartment of Plant Protection, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.
Hamed HamishehkarDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Nicolas DesneuxUniversité Côte d'Azur, INRAE, CNRS, UMR ISA, 06000, Nice, France.
Antonio BiondiDepartment of Agriculture, Food and Environment, University of Catania, Catania, Italy.
Khalid HaddiDepartment of Entomology, Federal University of Lavras, Lavras, MG, 37200-000, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is a new field in the pesticide industry. Nanopesticides represent an emerging technological tool that offers a range of benefits including increased efficacy, durability, and reduction in the amounts of used active ingredients. However, due to the lack of studies on the toxicity and the sublethal effects on pests and natural enemies, the extent of action and fate of these nanopesticdes is still not fully understood limitting thus their wide use. In this study, we encapsulated the pirimicarb insecticide using nanostructured lipid carriers (NLC) and investigated the toxicity and sublethal effects (LC

Indexed as

AphidsInsecticidesAnimalsCarbamatesInsectaPyrimidinesCarbamatesInsecticidespirimicarbPyrimidinesIntegrated pest managementLife tableNanopesticidesNanostructured lipid carriersSublethal effect

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.